Meritxell Gironella
Overview
Explore the profile of Meritxell Gironella including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
56
Citations
1947
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gomez-Matas J, Duran-Sanchon S, Lozano J, Ferrero G, Tarallo S, Pardini B, et al.
iScience
. 2024 Mar;
27(3):109283.
PMID: 38450150
Small nucleolar RNAs (snoRNAs) have been identified dysregulated in several pathologies, and these alterations can be detected in tissues and in circulation. The main aim of this study was to...
2.
Martinez-Bosch N, Cristobal H, Iglesias M, Gironella M, Barranco L, Visa L, et al.
EBioMedicine
. 2022 Jan;
75:103797.
PMID: 34973624
Background: Early diagnosis is crucial for patients with pancreatic ductal adenocarcinoma (PDAC). The AXL receptor tyrosine kinase is proteolytically processed releasing a soluble form (sAXL) into the blood stream. Here...
3.
Boces-Pascual C, Mata-Ventosa A, Martin-Satue M, Boix L, Gironella M, Pastor-Anglada M, et al.
Cell Mol Life Sci
. 2021 Oct;
78(23):7505-7518.
PMID: 34647142
High-affinity uptake of natural nucleosides as well as nucleoside derivatives used in anticancer therapies is mediated by human concentrative nucleoside transporters (hCNTs). hCNT1, the hCNT family member that specifically transports...
4.
Carrascal M, Areny-Balaguero A, de-Madaria E, Cardenas-Jaen K, Garcia-Rayado G, Rivera R, et al.
J Pathol
. 2021 Oct;
256(1):83-92.
PMID: 34599510
As acute pancreatitis progresses to the severe form, a life-threatening systemic inflammation is triggered. Although the mechanisms involved in this process are not yet well understood, it has been proposed...
5.
Castells A, Gironella M
Clin Gastroenterol Hepatol
. 2021 Jul;
20(3):e642-e643.
PMID: 34229036
No abstract available.
6.
Fernandez-Castaner E, Vila-Casadesus M, Vila-Navarro E, Parra C, Lozano J, Castells A, et al.
Cancers (Basel)
. 2021 Jun;
13(10).
PMID: 34069007
Intraductal papillary mucinous neoplasms (IPMN) are pancreatic cystic lesions that can develop into pancreatic ductal adenocarcinoma (PDAC). Although there is an increasing incidence of IPMN diagnosis, the mechanisms of formation...
7.
Vila-Navarro E, Fernandez-Castaner E, Rovira-Rigau M, Raimondi G, Vila-Casadesus M, Lozano J, et al.
Oncogenesis
. 2020 May;
9(5):43.
PMID: 32366853
Biomarkers and effective therapeutic agents to improve the dismal prognosis of pancreatic ductal adenocarcinoma (PDAC) are urgently required. We aimed to analyze the prognostic value and mechanistic action of miR-93...
8.
Duran-Sanchon S, Moreno L, Gomez-Matas J, Auge J, Serra-Burriel M, Cuatrecasas M, et al.
Clin Gastroenterol Hepatol
. 2020 Mar;
19(2):323-330.e1.
PMID: 32113893
Background & Aims: An algorithm based on fecal levels of 2 microRNAs (miR-421 and miR-27a-3p), fecal hemoglobin concentration, and patient age and sex can identify patients with advanced colorectal neoplasia....
9.
Duran-Sanchon S, Vila-Navarro E, Marcuello M, Lozano J, Munoz J, Cubiella J, et al.
Biomolecules
. 2019 Dec;
10(1).
PMID: 31877644
Background: Circulating microRNA (miRNA) analysis is a growing research field. However, it usually requires an endogenous control or housekeeping (HK) in order to normalize expression of specific miRNAs throughout different...
10.
Duran-Sanchon S, Moreno L, Auge J, Serra-Burriel M, Cuatrecasas M, Moreira L, et al.
Gastroenterology
. 2019 Oct;
158(4):947-957.e4.
PMID: 31622624
Background & Aims: Screening for colorectal cancer (CRC) is effective in the population at average risk. The most extended strategy in organized programs involves the fecal immunochemical test, which is...